By Professor Stephen John Kerr

Journal articles

Wongsawat J; Puthanakit T; Kanjanavanit S; Hansudewechakul R; Ngampiyasakul C; Kerr SJ; Ubolyam S; Suwanlerk T; Kosalaraksa P; Luesomboon W; Ngo-Giang-Huong N; Chandara M; Sapphon V; Ruxrungtham K; Ananworanich J, 2010, 'CD4 cell count criteria to determine when to initiate antiretroviral therapy in children', Pediatric Infectious Disease Journal, 29, pp. 966 - 968

Duncombe CJ; Kerr SJ; Liddy J; Avihingsanon A; Ruxrungtham K; Phanuphak P, 2010, 'Efficacy and tolerability of zidovudine 200 mg twice a day as part of combination antiretroviral therapy for 96 weeks', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 54, pp. e19 - e20

Avihingsanon A; Apornpong T; Kerr SJ; Ananworanich J; Ruxrungtham K, 2010, 'Long‐term efficacy and safety of low‐dose ritonavir‐boosted atazanavir (ATV/r) 200/100 mg in HIV‐infected Thai patients', Journal of the International AIDS Society, 13, http://dx.doi.org/10.1186/1758-2652-13-s4-p60

Hemachandra A; Puls RL; Kerr SJ; Saengthong N; Pussadee K; Emery S; Phanuphak P; Ruxrungtham K, 2009, 'P15-01. Willingness to participate in actual preventive HIV vaccine phase I/IIa trial in Bangkok, Thailand', Retrovirology, 6, http://dx.doi.org/10.1186/1742-4690-6-S3-P202

Kerr S; Phanuphak P, 2009, 'An Asian perspective on HIV/AIDS', Asian Biomedicine, 3, pp. 9 - 14

Puthanakit T; Kerr SJ; Ananworanich J; Bunupuradah T; Boonrak P; Sirisanthana V, 2009, 'Pattern and predictors of immunologic recovery in human immunodeficiency virus-infected children receiving non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy', Pediatric Infectious Disease Journal, 28, pp. 488 - 492, http://dx.doi.org/10.1097/INF.0b013e318194eea6

Risica PM; Kerr S; Lawson E; Belhumeur R; Ankoma A, 2009, 'Self-report of sugar-sweetened beverage and fast food consumption by annual household income.', Medicine and health, Rhode Island, 92, pp. 63 - 64

Avihingsanon A; van der Lugt J; Kerr SJ; Gorowara M; Chanmano S; Ohata P; Lange J; Cooper DA; Phanuphak P; Burger DM; Ruxrungtham K, 2009, 'A low dose of ritonavir-boosted atazanavir provides adequate pharmacokinetic parameters in HIV-1-infected Thai adults', Clinical Pharmacology and Therapeutics, 85, pp. 402 - 408

Kerr SJ; Phanuphak P, 2009, 'An Asian perspective on HIV/AIDS', Asian Biomedicine, 3, pp. 9 - 14

Puthanakit T; Kerr SJ; Ananworanich J; Bunupuradah T; Boonrak P; Sirisanthana T, 2009, 'Pattern and predictors of immunologic recovery in human immunodeficiency virus-infected children receiving non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy', Pediatric Infectious Disease Journal, 28, pp. 488 - 492, http://dx.doi.org/10.1097/INF0b13e31894eea6

van der Lugt J; Gorowara M; Avihingsanon A; Burger D; Ananworanich J; Sringam K; wit F; Kerr SJ; Lange JM; Ruxrungtham K, 2009, 'Reducing the boosting dose of ritonavir does not affect saquinavir levels in HIV-infected individuals', AIDS, 23, pp. 1176 - 1179, http://www.ncbi.nlm.nih.gov/pubmed/19451794

Liddy JC; Duncombe C; Kerr SJ; Chapman RS, 2008, 'GENDER DIFFERENCES IN BASELINE CHARACTERISTICS AND VIROLOGICAL RESPONSE IN ANTIRETROVIRAL-NAIVE HIV PATIENTS IN THAILAND COMMENCING HAART', JOURNAL OF HEALTH RESEARCH, 22, pp. 15 - 20, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000453182700004&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Layton MR; Kerr SJ; Chetchotisakd P, 2008, 'IMPACT OF PATIENT-HEALTH CARE PROVIDER COMMUNICATION: THE HIV/AIDS PATIENTS' PERSPECTIVES', VALUE IN HEALTH, 11, pp. A442 - A443, http://dx.doi.org/10.1016/S1098-3015(10)66490-X

Layton MR; Chadbunchachai S; Kerr SJ, 2008, 'PAIN MANAGEMENT IN THAILAND: IMPLICATION FOR BETTER PATIENT EDUCATION', VALUE IN HEALTH, 11, pp. A646 - A647, http://dx.doi.org/10.1016/S1098-3015(10)67105-7

Avihingsanon A; van der Lugt J; Kerr S; Gorowara M; Chanmano S; Cooper DA; Phanuphak P; Burger D; Ruxrungtham K, 2008, 'Impact of age on pharmacokinetics of boosted atazanavir 300/100 in Thai HIV-infected patients', Journal of the International AIDS Society, 11, pp. P244 - P244, http://dx.doi.org/10.1186/1758-2652-11-s1-p244

Mangclaviraj S; Kerr SJ; Chaithongwongwatthana S; Ananworanich J; Hirschel B; Emery S; Cooper DA; Chotnopparatpattara P; Ruxrungtham K; Phanuphak P, 2008, 'Nadir CD4 count and monthly income predict cervical squamous cell abnormalities in HIV-positive women in a resource-limited setting', International Journal of STD and AIDS, 19, pp. 529 - 532

Corno AF; Ladusans EJ; Pozzi M; Kerr S, 2007, 'FloWatch versus conventional pulmonary artery banding', Journal of Thoracic and Cardiovascular Surgery, 134, pp. 1413 - 1420, http://dx.doi.org/10.1016/j.jtcvs.2007.03.065

Safreed-Harmon K; Siripong A; Kerr SJ; Gruskin S; Pancharoen C; Ananworanich J, 2007, 'Antiretroviral therapy adherence did not differ between Thai children with biological and those with nonbiological parents', CLINICAL INFECTIOUS DISEASES, 45, pp. 669 - 670, http://dx.doi.org/10.1086/520784

Safreed-Harmon K; Siripong A; Kerr SJ; Gruskin S; Pancharoen C; Ananworanich J, 2007, 'Antiretroviral therapy adherence did not differ between thai children with biological and those with nonbiological parents [7]', Clinical Infectious Diseases, 45, pp. 669 - 670, http://dx.doi.org/10.1086/520784

Baden LR; Marty FM, 2007, 'Posaconazole for invasive aspergillosis?', CLINICAL INFECTIOUS DISEASES, 45, pp. 664 - 664, http://dx.doi.org/10.1086/519510

Kerr SJ; Duncombe CJ; Avihingsanon A; Ananworanich J; Boyd MA; Sopa B; Chuenyam T; Cooper DA; Lange JM; Phanuphak P; Ruxrungtham K, 2007, 'Dyslipidemia in an Asian population after treatment for two years with protease inhibitor-containing regimens.', Journal of the International Association of Physicians in AIDS Care, 6, pp. 36 - 46

Boom J; Kosters E; Duncombe CJ; Kerr SJ; Hirschel B; Ruxrungtham K; de Mast Q; Kosalaraksa P; Ulbolyam S; Jupimai T; Ananworanich J, 2007, 'Ferritin levels during structured treatment interruption of highly active antiretroviral therapy.', HIV Medicine, 8, pp. 388 - 395

Vemula S; Kerr SJ; Pancharoen C; Siripong A; Kosalaraksa P; Engchanil C; Chuamchaitrakool A; Intasan J; Lumbiganond P; Phanuphak P; Ananworanich J, 2007, 'Incidence and risk factors for non-nucleoside reverse transcriptase inhibitors (NNRTI)-related rash in Thai children with HIV infection.', Journal of the Medical Association of Thailand, 90, pp. 2437 - 2441

Kerr SJ; Lange J; Cooper DA; Phanupak P; Ruxrungtham K, 2006, 'HIV-NAT Promoting Rational and Evidence-based Use of Antiretroviral Therapies', Asia-Pacific Biotech News, 10, pp. 1229 - 1234, http://dx.doi.org/10.1142/s0219030306001820

Avihingsanon A; Avihingsanon Y; Darnpornprasert P; Kerr SJ; Ungsedhapand C; Duncombe CJ; Ubolyam S; Ruxrungtham K; Phanuphak P, 2006, 'High prevalence of indinavir-associated renal complications in Thai HIV-infected patients.', Journal of the Medical Association of Thailand, 89, pp. S21 - S27

Duncombe CJ; Kerr SJ; Ruxrungtham K; Dore GJ; Law MG; Emery S; Lange J; Phanuphak P; Cooper DA, 2005, 'HIV disease progression in a patient cohort treated via a clinical research network in a resource limited setting', AIDS, 19, pp. 169 - 178

Glaser AN, 2004, 'Computer aided prescribing - Software needs to take account of how doctors prescribe', BRITISH MEDICAL JOURNAL, 328, pp. 1565 - 1565, http://dx.doi.org/10.1136/bmj.328.7455.1565-b

Glaser AN; Farrar K; Slee A; Hughes D; Marsh P; Makin C; Wong K; Tam P; Liaw ST; Kerr S, 2004, 'Computer aided prescribing [3] (multiple letters)', British Medical Journal, 328, pp. 1565 - 1566

Kerr SJ; Mant A; Horn FE; McGeechan K; Sayer GRP, 2004, 'Lessons from early large-scale adoption of celecoxib and rofecoxib by Australian general practitioners - Reply', MEDICAL JOURNAL OF AUSTRALIA, 180, pp. 311 - 311, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000220468700022&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Florin THJ; Kerr SJ; Mant A; Horn FE; McGeechan K; Sayer GP; Dowden JS, 2004, 'Lessons from early large-scale adoption of celecoxib and rofecoxib by Australian general practitioners (multiple letters) [4]', Medical Journal of Australia, 180, pp. 310 - 311, http://dx.doi.org/10.5694/j.1326-5377.2004.tb05938.x

Liaw ST; Kerr S, 2004, 'Computer aided prescribing: decision support needs to be evidence based.', BMJ (Clinical research ed.), 328, pp. 1566, http://dx.doi.org/10.1136/bmj.328.7455.1566-a

Kerr SJ; Mant A; Horn FE; McGeechan K; Sayer GP, 2004, 'Lessons from early large‐scale adoption of celecoxib and rofecoxib by Australian general practitioners', Medical Journal of Australia, 180, pp. 310 - 312, http://dx.doi.org/10.5694/j.1326-5377.2004.tb05939.x

Kerr SJ; Mant A; Horn FE; McGeechan K; Sayer GP, 2003, 'Lessons from early large-scale adoption of celecoxib and rofecoxib by Australian general practitioners', Medical Journal of Australia, 179, pp. 403 - 407, http://dx.doi.org/10.5694/j.1326-5377.2003.tb05616.x

Ahearn MD; Kerr SJ, 2003, 'General practitioners' perceptions of the pharmaceutical decision-support tools in their prescribing software', Medical Journal of Australia, 179, pp. 34 - 37, http://dx.doi.org/10.5694/j.1326-5377.2003.tb05415.x

Smythe GA; Braga O; Brew BJ; Grant RS; Guillemin GJ; Kerr SJ; Walker DW, 2002, 'Concurrent quantification of quinolinic, picolinic and nicotinic acids using electron-capture negative-ion gas chromatography-mass spectrometry', Analytical Biochemistry, 301, pp. 21 - 26

Guillemin GJ; Kerr SJ; Pemberton LA; Smith DG; Smythe GA; Armati PJ; Brew BJ, 2001, 'IFN-b1b induces Kynurenine pathway metabolism in human macrophages:potential implications for multiple sclerosis treatment', Journal of Interferon and Cytokine Research, pp. 1097 - 1101

Guillemin GJ; Kerr SJ; Smythe GA; Smith DG; Kapoor V; Armati PJ; Croitoru J; Brew BJ, 2001, 'Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection', Journal of Neurochemistry, pp. 842 - 853

Smith DG; Guillemin GJ; Pemberton LA; Kerr SJ; Nath A; Smythe GA; Brew BJ, 2001, 'Quinolinic acid is produced by macrophages stimulated by platelet activating factor, NeF and Tat', Journal of Neurovirology, pp. 56 - 60

Guillemin GJ; Smith DG; Kerr SJ; Smythe GA; Kapoor V; Armati P; Brew BJ, 2000, 'Characterisation of kynurenine pathway metabolism in human astrocytes and implications in neuropathogenesis', Redox Report, 5, pp. 108 - 111

Guillemin GJ; Smith DD; Kerr SJ; Smythe GA; Kapoor V; Armati P; Brew BJ, 2000, 'Characterisation of kynurenine pathway metabolism in human astrocytes and implications in neutopathogenesis', Redox Report, pp. 108 - 111

Guillemin GJ; Kerr SJ; Smythe GA; Armati P; Brew BJ, 1999, 'Kynurenine pathway metabolism in human astrocytes', Advances in Experimental Medicine and Biology, pp. 125 - 131

Kerr SJ; Pemberton LA; Guillemin GJ; Smythe G; Brew BJ, 1998, 'Interferon-beta induces kynurenine pathway metabolism inhuman macrophages', NEUROLOGY, 50, pp. A34 - A34, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000073240900095&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kerr SJ; Amarti PJ; Guilbaud G; Brew BJ, 1998, 'Chronic exposure of human neurons to quinolinic acid results in neuronal changes consistent with AIDS dementia complex', AIDS, 12, pp. 355 - 363

Kerr SJ; Armati PJ; Pemberton LA; Smythe G; Brew BJ, 1997, 'Kynurenine pathway inhibition with 6-chloro-D-tryptophan reduces neurotoxicity of HIV-1 infected macrophage supernatants', NEUROLOGY, 48, pp. 2008 - 2008, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997XG87100226&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Pemberton LA; Kerr SJ; Brew BJ, 1997, 'HIV-1 gp120 does not induce quinolinic acid production by macrophages', Journal of Neurovirology, pp. 86 - 87

Kerr SJ; Armati P; Pemberton LA; Smythe GA; Tattam B; Brew BJ, 1997, 'Kynurenine pathway inhibition reduces neurotoxicity of HIV-1-infected macrophages', Neurology, pp. 1671 - 1681

Pemberton LA; Kerr SJ; Smythe GA; Brew BJ, 1997, 'Quinolinic acid production by macrophages stimulate with interferon y tumour necrosis factor a and interferon a', Journal of Interferon and Cytokine Research, 17, pp. 589 - 595

Pemberton LA; Kerr SJ; Smythe GA; Brew BJ, 1997, 'Quinolinic acid production by macrophages stimulated with IFN-gamma, TNF-alpha, and IFN-alpha', Journal of Interferon and Cytokine Research, 17, pp. 589 - 595

Kerr SJ; Armati P; Brew BJ, 1996, 'Neurocytotoxicity of quinolinic acid in human brain cultures', Journal of Neurovirology, 1, pp. 375 - 380

Chen XZ; Farnsworth AE; Jones ODH; Kerr SJ; Crawford M; Pracy E, 1994, 'EXTRACORPOREAL MEMBRANE OXYGENATION FOR PERI‐OPERATIVE CARDIOPULMONARY SUPPORT IN AN INFANT AFTER REPAIR OF TOTAL ANOMALOUS PULMONARY VENOUS CONNECTION', Australian and New Zealand Journal of Surgery, 64, pp. 799 - 800, http://dx.doi.org/10.1111/j.1445-2197.1994.tb04546.x

Back to profile page